A practitioner asking should I offer MIC? in 2026 is implicitly asking why would I, when I can prescribe a GLP-1? The honest answers are narrower than the marketing, but they are real: Patients who cannot or will not take a GLP-1
As a result, many of the peptides potential benefits remain theoretical
One such effort is the ongoing Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3) trial at Vanderbilt University Medical Center, which is evaluating semaglutide in adults with obesity and asthma who do not have diabetes
The available data suggest that beginning at low doses (e.g., 10 mg) and titrating gradually to 75-100 mg if tolerated is an acceptable dosing regimen
No complicated preparation
At Newington Pharmacy, we often recommend vitamin B12 injections as an effective way to boost health and address deficiencies